Skip to content

Type: White Papers

White Paper | Conference on Clinical Cancer Research 2009 – Panel 1 | Data Submission Standards and Evidence Requirements

White Paper | Conference on Clinical Cancer Research 2010 – Panel 4 | Using Patient-Initiated Study Participation in the Development of Evidence for Personalized Cancer Therapy

White Paper | Conference on Clinical Cancer Research 2010 – Panel 3 | Integrating Pain Metrics into Oncologic Clinical and Regulatory Decision-Making

White Paper | Conference on Clinical Cancer Research 2010 – Panel 1 | Adaptive Clinical Trials Designs for Simultaneous Testing of Matched Diagnostics and Therapeutics

White Paper | Conference on Clinical Cancer Research 2011 – Panel 4 | Development Paths for New Drugs with Large Treatment Effects Seen Early

White Paper | Conference on Clinical Cancer Research 2011 – Panel 3 | Symptom Measurement in Clinical Trials

White Paper | Conference on Clinical Cancer Research 2011 – Panel 2 | Evidence for Use of Maintenance Therapy

White Paper | Conference on Clinical Cancer Research 2011 – Panel 1 | Alternative Trial Designs Based on Tumor Genetics/Pathway Characteristics Instead of Histology

White Paper | Friends/Alexandria Forum 2012 | Blueprint for Future Drug/Diagnostic Co-Development 2012: Pre-Forum Report – Considerations for the successful co-development of targeted cancer therapies and companion diagnostics

White Paper | Conference on Clinical Cancer Research 2012 – Panel 1 | Re-evaluating Criteria for Accelerated Approval